본문 바로가기
KERD
논문KCI 등재

The potential of mesenchymal stem cells derived from amniotic membrane and amniotic fluid for neuronal regenerative therapy

김민규|김은영|이경본
생화학분자생물학회 (Korean Society Of Biochemistry And Molecular Biology)|2014.03|BMB Reports|제47권 제3호|pp. 135-140

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

Mesenchymal stem cellAmniotic fluidAmniotic membraneNeuronal diseaseRegeneration therapy
주제분류화학

초록

The mesenchymal stem cells (MSCs), which are derived fromthe mesoderm, are considered as a readily available source fortissue engineering. They have multipotent differentiationcapacity and can be differentiated into various cell types. Many studies have demonstrated that the MSCs identified fromamniotic membrane (AM-MSCs) and amniotic fluid (AF-MSCs)are shows advantages for many reasons, including thepossibility of noninvasive isolation, multipotency, self-renewal,low immunogenicity, anti-inflammatory and nontumorigenicityproperties, and minimal ethical problem. The AF-MSCs andAM-MSCs may be appropriate sources of mesenchymal stemcells for regenerative medicine, as an alternative to embryonicstem cells (ESCs). Recently, regenerative treatments such astissue engineering and cell transplantation have shownpotential in clinical applications for degenerative diseases. Therefore, amnion and MSCs derived from amnion can beapplied to cell therapy in neuro-degeneration diseases. In thisreview, we will describe the potential of AM-MSCs andAF-MSCs, with particular focus on cures for neuronaldegenerative diseases.

Abstract

The mesenchymal stem cells (MSCs), which are derived fromthe mesoderm, are considered as a readily available source fortissue engineering. They have multipotent differentiationcapacity and can be differentiated into various cell types. Many studies have demonstrated that the MSCs identified fromamniotic membrane (AM-MSCs) and amniotic fluid (AF-MSCs)are shows advantages for many reasons, including thepossibility of noninvasive isolation, multipotency, self-renewal,low immunogenicity, anti-inflammatory and nontumorigenicityproperties, and minimal ethical problem. The AF-MSCs andAM-MSCs may be appropriate sources of mesenchymal stemcells for regenerative medicine, as an alternative to embryonicstem cells (ESCs). Recently, regenerative treatments such astissue engineering and cell transplantation have shownpotential in clinical applications for degenerative diseases. Therefore, amnion and MSCs derived from amnion can beapplied to cell therapy in neuro-degeneration diseases. In thisreview, we will describe the potential of AM-MSCs andAF-MSCs, with particular focus on cures for neuronaldegenerative diseases.

참고문헌 (64)

  1. Hak-Hyun Ryu, "Functional recovery and neural differentiation after transplantation of allogenic adipose-derived stem cells in a canine model of acute spinal cord injury", Journal of Veterinary Science, 10(4), pp.273~284 (2009), 대한수의학회
  2. Payushina, O. V., "Mesenchymal stem cells: Sources, phenotype, and differentiation potential", Biology Bulletin, 33, pp.2~18 (2006)
  3. Choi, S. A., "Isolation of canine mesenchymal stem cells from amniotic fluid and differentiation into hepatocyte- like cells", In. Vitro. Cell Dev. Biol. Anim, 49, pp.42~51 (2013)
  4. Barzilay, R., "Induction of human mesenchymal stem cells into dopamine-producing cells with different differentiation protocols", Stem Cells and Development, 17, pp.547~554 (2008)
  5. Carraro, G., "Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages", Stem. Cells, 26, pp.2902~2911 (2008)
  6. Connell, J. P., "Amniotic Fluid-Derived Stem Cells for Cardiovascular Tissue Engineering Applications", Tissue Engineering Part B-Reviews, 19, pp.368~379 (2013)
  7. Sun, N. Z., "In vitro differentiation of human placenta-derived adherent cells into insulin- producing cells", J. Int. Med. Res, 37, pp.400~406 (2009)
  8. Ghislain Moussavou, "Role of gangliosides in the differentiation of human mesenchymal-derived stem cells into osteoblasts and neuronal cells", BMB Reports, 46(11), pp.527~532 (2013), 생화학분자생물학회
  9. Rui-Dong Li, "Biphasic effects of TGFβ1 on BMP9-induced osteogenic differentiation of mesenchymal stem cells", BMB Reports, 45(9), pp.509~514 (2012), 생화학분자생물학회
  10. Toda, A., "The potential of amniotic membrane", amnion-derived cells for regeneration of various tissues, 2007, pp.105, 215~228
  11. Evans, M. J, "Establishment in culture of pluripotential cells from mouse embryos", Nature, 292, pp.154~156 (1981)
  12. Thomson, J. A., "Embryonic stem cell lines derived from human blastocysts", Science, 282, pp.1145~1147 (1998)
  13. Amit, M., "Human feeder layers for human embryonic stem cells", Biol. Reprod, 68, pp.2150~2156 (2003)
  14. Seminatore, C., "The postischemic environment differentially impacts teratoma or tumor formation after transplantation of human embryonic stem cell-derived neural progenitors", Stroke, 41, pp.153~159 (2010)
  15. Abad, M., "Reprogramming in vivo produces teratomas and iPS cells with totipotency features", Nature, 502, pp.340~345 (2013)
  16. Medvedev, S. P., "Induced Pluripotent Stem Cells: Problems and Advantages when Applying them in Regenerative Medicine", Acta. Naturae, 2, pp.18~28 (2010)
  17. Dua, H. S., "Amniotic membrane transplantation", Br. J. Ophthalmol, 83, pp.748~752 (1999)
  18. Tamagawa, T., "Differentiation of mesenchymal cells derived from human amniotic membranes into hepatocyte- like cells in vitro", Hum. Cell, 20, pp.77~84 (2007)
  19. in't Anker, P. S., "Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta", Stem Cells, 22, pp.1338~1345 (2004)
  20. Adinolfi, M., "Expression of HLA antigens, beta 2-microglobulin and enzymes by human amniotic epithelial cells", Nature, 295, pp.325~327 (1982)
  21. Miki, T., "Stem cell characteristics of amniotic epithelial cells", Stem Cells, 23, pp.1549~1559 (2005)
  22. Tseng, S. C., "Suppression of transforming growth factor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix", J. Cell Physiol, 179, pp.325~335 (1999)
  23. Kim, J. S., "Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn", Exp. Eye Res, 70, pp.329~337 (2000)
  24. Torricelli, F., "Identification of hematopoietic progenitor cells in human amniotic fluid before the 12th week of gestation", Ital. J. Anat. Embryol, 98, pp.119~126 (1993)
  25. Shay, J. W., "Hayflick, his limit, and cellular ageing", Nat. Rev. Mol. Cell Biol, 1, pp.72~76 (2000)
  26. Tsai, M. S., "Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol", Hum. Reprod, 19, pp.1450~1456 (2004)
  27. De Coppi, P., "Isolation of amniotic stem cell lines with potential for therapy", Nat. Biotechnol, 25, pp.100~106 (2007)
  28. Prusa, A. R., "Amniotic fluid cells and human stem cell research: a new connection", Med. Sci. Monit, 8, pp.253~257 (2002)
  29. Okano, H., "Transplantation of neural stem cells into the spinal cord after injury", Semin. Cell Dev. Biol, 14, pp.191~198 (2003)
  30. Tropel, P., "Functional neuronal differentiation of bone marrow-derived mesenchymal stem cells", Stem Cells, 24, pp.2868~2876 (2006)
  31. Tio, M., "Roles of db-cAMP, IBMX and RA in aspects of neural differentiation of cord blood derived mesenchymal-like stem cells", PLoS One, 5, pp.e9398~ (2010)
  32. Kim, E. Y, "Neuronal cell differentiation of mesenchymal stem cells originating from canine amniotic fluid", Hum. Cell (2013)
  33. Tremblay, R. G., "Differentiation of mouse Neuro 2A cells into dopamine neurons", J. Neurosci. Methods, 186, pp.60~67 (2010)
  34. Uchida, S., "Neurotrophic function of conditioned medium from human amniotic epithelial cells", J. Neurosci. Res, 62, pp.585~590 (2000)
  35. Pan, H. C., "Enhanced regeneration in injured sciatic nerve by human amniotic mesenchymal stem cell", J. Clin. Neurosci, 13, pp.570~575 (2006)
  36. Kakishita, K., "Human amniotic epithelial cells produce dopamine and survive after implantation into the striatum of a rat model of Parkinson's disease: A potential source of donor for transplantation therapy", Experimental Neurology, 165, pp.27~34 (2000)
  37. Portmann-Lanz, C. B., "Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration", Am. J. Obstet. Gynecol, 194, pp.664~673 (2006)
  38. Ariga, H., "Neuroprotective function of DJ-1 in Parkinson's disease", Oxid. Med. Cell Longev, 2013, pp.683920~ (2013)
  39. Tseng, S. C., "Intraoperative mitomycin C and amniotic membrane transplantation for fornix reconstruction in severe cicatricial ocular surface diseases", Ophthalmology, 112, pp.896~903 (2005)
  40. Mohammadi, A. A., "Effect of amniotic membrane on graft take in extremity burns", Burns, 39, pp.1137~1141 (2013)
  41. Khademi, B., "Clinical application of amniotic membrane as a biologic dressing in oral cavity and pharyngeal defects after tumor resection", Arch. Iran. Med, 16, pp.503~506 (2013)
  42. Samandari, M. H., "Use of amnion as a graft material in vestibuloplasty: a preliminary report", Oral. Surg. Oral. Med. Oral. Pathol. Oral Radiol. Endod, 97, pp.574~578 (2004)
  43. Gharib, M., "Use of amniotic grafts in the repair of gastroschisis", Pediatr. Surg. Int, 11, pp.96~99 (1996)
  44. Liu, Y., "Amniotic stem cell transplantation therapy for type 1 diabetes: a case report", J. Int. Med. Res, 41, pp.1370~1377 (2013)
  45. Steigman, S. A., "Sternal repair with bone grafts engineered from amniotic mesenchymal stem cells", J. Pediatr. Surg, 44, pp.1120~1126 (2009)
  46. Wu, Z. Y., "Transplantation of human amniotic epithelial cells improves hindlimb function in rats with spinal cord injury", Chin. Med. J. (Engl), 119, pp.2101~2107 (2006)
  47. Xue, H., "Development of a chemically extracted acellular muscle scaffold seeded with amniotic epithelial cells to promote spinal cord repair", J. Biomed. Mater. Res. A, 101, pp.145~156 (2013)
  48. de Weerd, L., "A new approach in the repair of a myelomeningocele using amnion and a sensate perforator flap", J. Plast. Reconstr. Aesthet. Surg, 66, pp.860~863 (2013)
  49. McCarthy, S., "Craniofacial anomalies in the amniotic band disruption complex", Pediatr. Radiol, 14, pp.44~46 (1984)
  50. Doret, M., "Premature preterm rupture of the membrane diagnosis in early pregnancy: PAMG-1 and IGFBP-1 detection in amniotic fluid with biochemical tests", Clin. Biochem, 46, pp.1816~1819 (2013)
  51. Skardal, A., "Bioprinted amniotic fluid- derived stem cells accelerate healing of large skin wounds", Stem Cells Transl. Med, 1, pp.792~802 (2012)
  52. Weber, B., "Prenatally engineered autologous amniotic fluid stem cell-based heart valves in the fetal circulation", Biomaterials, 33, pp.4031~4043 (2012)
  53. Villani, V., "Amniotic fluid stem cells prevent beta-cell injury", Cytotherapy, 16, pp.41~55 (2014)
  54. Tajiri, N., "Intravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats", PLoS One, 7, pp.e43779~ (2012)
  55. Liu, Y. W., "Xenografted human amniotic fluid-derived stem cell as a cell source in therapeutic angiogenesis", Int. J. Cardiol, 168, pp.66~75 (2013)
  56. Werber, B., "A prospective study of 20 foot and ankle wounds treated with cryopreserved amniotic membrane and fluid allograft", J. Foot Ankle Surg, 52, pp.615~621 (2013)
  57. Tsai, M. S., "Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells", Biol. Reprod, 74, pp.545~551 (2006)
  58. McLaughlin, D., "Stable expression of a neuronal dopaminergic progenitor phenotype in cell lines derived from human amniotic fluid cells", J. Neurosci. Res, 83, pp.1190~1200 (2006)
  59. Xue, S., "Therapeutic effects of human amniotic epithelial cell transplantation on double-transgenic mice co-expressing APPswe and PS1DeltaE9-deleted genes", Sci. China Life Sci, 55, pp.132~140 (2012)
  60. Chang, Y. J., "Amniotic fluid stem cells with low gamma-interferon response showed behavioral improvement in parkinsonism rat model", PLoS One, 8, pp.e76118~ (2013)
  61. Pan, H. C., "Human amniotic fluid mesenchymal stem cells in combination with hyperbaric oxygen augment peripheral nerve regeneration", Neurochem. Res, 34, pp.1304~1316 (2009)
  62. Rehni, A. K., "Amniotic fluid derived stem cells ameliorate focal cerebral ischaemia-reperfusion injury induced behavioural deficits in mice", Behav. Brain Res, 183, pp.95~100 (2007)
  63. Cheng, F. C., "Enhancement of regeneration with glia cell line-derived neurotrophic factor-transduced human amniotic fluid mesenchymal stem cells after sciatic nerve crush injury", J. Neurosurg, 112, pp.868~879 (2010)
  64. Sankar, V., "Role of human amniotic epithelial cell transplantation in spinal cord injury repair research", Neuroscience, 118, pp.11~17 (2003)

관련 논문AI추천

Neurorestoration Induced by Mesenchymal Stem Cells: Potential Therapeutic Mechanisms for Clinical Trials서정화, 조성래연세대학교의과대학 · Yonsei Medical Journal2012 · 제53권 제6호Differentiation of Dopaminergic Neurons from Mesenchymal-Like Stem Cells Derived from Human Umbilical Cord Vein감경윤, 강성구, 강아름, 김주란, 김해권, 도병록, 이진하, 이채연, Anjela Melinda Jalin한국발생생물학회 · 발생과 생식2009 · 제13권 제3호Usage of Human Mesenchymal Stem Cells in Cell-based Therapy: Advantages and Disadvantages김희정, 박정수한국발생생물학회 · 발생과 생식2017 · 제21권 제1호Isolation of human mesenchymal stem cells from the skin and their neurogenic differentiation in vitro강동호, 박봉욱, 변준호, Eun-Ju Kang, Gyu-Jin Rho, Mun-Jeong Choi, Seong-Cheol Park대한구강악안면외과학회 · 대한구강악안면외과학회지2012 · 제38권 제6호Molecular Characterization of Neurally Differentiated Human Bone Marrow-derived Clonal Mesenchymal Stem Cells송순욱, 이택기, 이현주, 전명신, 조윤경대한면역학회 · Immune Network2014 · 제14권 제1호Induction of a Neuronal Phenotype from Human Bone Marrow-Derived Mesenchymal Stem Cells이승표, Heekyung Jung, Hwan-Woo Park, Jung-Sun Cho, Ki-Suk Paik, Mi-Sook Chang, Soonyi Oh대한구강생물학회 · International Journal of Oral Biology2009 · 제34권 제4호

이 간행물의 다른 논문 (7건)

4-1BB (CD137), an inducible costimulatory receptor, as a specific target for cancer therapyDass S. Vinay, 권병세pp. 122-129In vitro and in vivo application of anti-cotinine antibody and cotinine-conjugated compounds김효리, 윤수민, 정준호pp. 130-134Proteomics approaches for the studies of bone metabolism이지현, 조제열pp. 141-148Small-molecule probes elucidate global enzyme activity in a proteomic context이준석, 유영화, 윤창노pp. 149-157Tumor bioenergetics: An emerging avenue for cancer metabolism targeted therapy정재호, 기현정pp. 158-166
원문 보기